AJOONI fundamentals

Key facts

Market capitalization‪1.08 B‬INR
Founded2010
CEOJasjot Singh
About

Ajooni Biotech Ltd. engages in the manufacturing, production, processing, and supply of cattle feed nutrients and animal health care supplements. Its products include energy plus, milk booster, buff power, hiffer, and nurture calf starter. The company was founded on February 17, 2010 and is headquartered in Mohali, India.

Ownership
‪‪172.24 M‬‬
Closely held shares
‪‪107.64 M‬‬ (62.49%)
Free Float shares
‪‪64.60 M‬‬ (37.51%)
Closely held shares
‪‪107.64 M‬‬ (62.49%)
Free Float shares
‪‪64.60 M‬‬ (37.51%)
Capital structure
Market cap
‪‪1.08 B‬‬
Debt
‪‪20.61 M‬‬
Cash & equivalents
‪‪175.92 M‬‬
Enterprise value
‪‪924.66 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.08 B‬‬
Price to earning ratio (P/E)
31.27x
Price to sales ratio (P/S)
1.03x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
31.27x
Price to sales ratio (P/S)
1.03x
Valuation ratios
‪0.00‬
‪0.40‬
‪0.80‬
‪1.20‬
‪1.60‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪1.5%‬
‪2.3%‬
‪3.1%‬
‪3.9%‬
‪4.7%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Animal Feed & Feed Supplements
By country
Period: 2023
India

Dividends

Dividend yield, history and sustainability

AJOONI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Assets
Liabilities